Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Daniel SW Tan"'
Autor:
Qingyuan Zhuang, Alwin Yaoxian Zhang, Ryan Shea Tan Ying Cong, Grace Meijuan Yang, Patricia Soek Hui Neo, Daniel SW Tan, Melvin LK Chua, Iain Beehuat Tan, Fuh Yong Wong, Marcus Eng Hock Ong, Sean Shao Wei Lam, Nan Liu
Publikováno v:
BMC Palliative Care, Vol 23, Iss 1, Pp 1-10 (2024)
Abstract Background Ex-ante identification of the last year in life facilitates a proactive palliative approach. Machine learning models trained on electronic health records (EHR) demonstrate promising performance in cancer prognostication. However,
Externí odkaz:
https://doaj.org/article/5408fd937f194a38b05c0bb53a3cb96b
Autor:
Chia-Chi Lin, Elena Garralda, Patrick Schöffski, David S. Hong, Lillian L. Siu, Miguel Martin, Michela Maur, Rina Hui, Ross A Soo, Joanne Chiu, Tian Zhang, Brigette Ma, Chrisann Kyi, Daniel SW Tan, Philippe A. Cassier, John Sarantopoulos, Andrew Weickhardt, Richard D. Carvajal, Jennifer Spratlin, Taito Esaki, Fréderic Rolland, Wallace Akerley, Barbara Deschler-Baier, Lawrence Rispoli, Tanay S. Samant, Niladri Roy Chowdhury, Daniel Gusenleitner, Eunice L. Kwak, Vasileios Askoxylakis, Filippo De Braud
Publikováno v:
OncoImmunology, Vol 13, Iss 1 (2024)
ABSTRACTIeramilimab, a humanized anti-LAG-3 monoclonal antibody, was well tolerated in combination with the anti-PD-1 antibody spartalizumab in a phase 1 study. This phase 2 study aimed to further investigate the efficacy and safety of combination tr
Externí odkaz:
https://doaj.org/article/fba32163599d40e7abcb0008f2589a1a
Autor:
Michael Menzel, Martina Kirchner, Klaus Kluck, Markus Ball, Susanne Beck, Michael Allgäuer, Christin Assmann, Johannes Schnorbach, Anna‐Lena Volckmar, Timothy Kwang Yong Tay, Hannah Goldschmid, Daniel SW Tan, Michael Thomas, Daniel Kazdal, Jan Budczies, Albrecht Stenzinger, Petros Christopoulos
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 10, Iss 2, Pp n/a-n/a (2024)
Abstract This study analyzed whether extended molecular profiling can predict the development of epidermal growth factor receptor (EGFR) gene T790M mutation, which is the most frequent resistance alteration in non‐small cell lung cancer (NSCLC) aft
Externí odkaz:
https://doaj.org/article/592032d0cf624a62bd5f0cb57fe2198c
Adjuvant Immunotherapy in Patients with Early-Stage Non-small Cell Lung Cancer and Future Directions
Publikováno v:
Current Treatment Options in Oncology. 23:1721-1731
Autor:
Daniel Sw Tan, Siqin Zhou, Stella Sl Goh, Yin Bun Cheung, Grace Meijuan Yang, Zhizhen Xu, Ravindran Kanesvaran, Patricia Sh Neo, Dawn Qq Chong, Xia Zhu, Alethea Cp Yee
Publikováno v:
Palliative Medicine. 35:1578-1589
Background: The benefit of specialist palliative care for cancer inpatients is established, but the best method to deliver specialist palliative care is unknown. Aim: To compare a consult model versus a co-rounding model; both provide the same conten
Autor:
Benjamin Solomon, Rebecca S Heist, Daniel SW Tan, Philippe A Cassier, Christophe Dooms, Eric Van Cutsem, Conor E Steuer, Neeltje Steeghs, Martin Schuler, Anas Gazzah, Martin Wermke, Enriqueta Felip, Herbert HF Loong, Maria J De Miguel Luken, Ross A Soo, Ashley Jaeger, Kun Xu, Xueying Chen, Xiaoming Cui, Heather Burks, Anna F Farago, Toshio Shimizu
Publikováno v:
Molecular Cancer Therapeutics. 20:LBA038-LBA038
Background Kirsten rat sarcoma virus (KRAS) is a GTPase that regulates cell signaling pathways involved in cell proliferation, survival, and tumorigenesis. Somatic mutations in KRAS resulting in a glycine to cysteine substitution at codon 12 (KRAS G1
Autor:
Chee Keong Toh, Whee Sze Ong, Daniel SW Tan, Quan Sing Ng, Ravindran Kanesvaran, Kam Weng Fong, Mei Kim Ang, Eng Huat Tan, Wan Teck Lim
Publikováno v:
Annals of the Academy of Medicine, Singapore. 46(9)
Introduction: We reviewed changes in clinical characteristics, treatment and survival of lung cancer patients in Singapore over the past decade. Materials and Methods: We reviewed all primary lung cancer cases from January 2004 to December 2013. Basi
Autor:
Alexander Drilon, Fabrice Barlesi, Filippo De Braud, Byoung Chul Cho, Myung-Ju Ahn, Salvatore Siena, Matthew G. Krebs, Chia-Chi Lin, Tom John, Daniel SW Tan, Takashi Seto, Rafal Dziadziuszko, Hendrick-Tobias Arkenau, Christian Rolfo, Jürgen Wolf, Chenglin Ye, Todd Riehl, Susan Eng, Robert C. Doebele
Publikováno v:
Cancer Research. 79:CT192-CT192
Background Entrectinib is a potent inhibitor of ROS1 (in addition to TRKA/B/C), designed to effectively penetrate the central nervous system (CNS); brain metastases are common in patients with advanced ROS1 fusion-positive NSCLC. Entrectinib achieves
Autor:
Xiaoqian Zhang, Ramanuj DasGupta, Daniel Sw Tan, Shen Yon Toh, Xue Lin Kwang, Tony Kh Lim, Anders Jacobsen Skanderup, Fui-Teen Chong, Gek San Tan, Hui-Sun Leong, N. Gopalakrishna Iyer, Dawn P. Lau
Publikováno v:
Cancer Research. 78:2591-2591
Squamous-cell cancers (SCCs) represent one of the commonest lethal malignancy worldwide. Despite evidence demonstrating that majority are addicted to Epidermal Growth Factor Receptor (EGFR)-signaling, targeting with monoclonal antibodies or tyrosine-
Autor:
H S Leong, J Low, G Periyasamy, J V Chan, R Dasgupta, Daniel Sw Tan, D P Lau, J L Y Koh, X L Kwang, S Rikka, X Zhang, N G Iyer
Publikováno v:
Annals of Oncology. 28:vii18